Literature DB >> 6794167

Preoperative radiotherapy for carcinoma of the esophagus.

B Launois, D Delarue, J P Campion, M Kerbaol.   

Abstract

From 21 March to 22 June 1976, 124 patients with squamous cell carcinoma of the esophagus were randomized for inclusion in a prospective trial of preoperative irradiation. Fifteen patients were excluded because of inoperability. Sixty-seven patients were randomly selected to receive 4,000 rads of cobalt radiation for eight days prior to operation; 57 patients were operated upon without receiving radiation therapy. No significant differences were noted between the two groups with regard to age, sex, tumor site, experience of the surgeon, method of approach or surgical technique. Eight esophageal resections were performed upon 47 of the 62 irradiated patients and 33 of the 47 nonirradiated patients. Of the 62 irradiated patients, 14 died during operation, compared with 11 of the 47 nonirradiated patients, the difference between the two groups not being statistically significant. Irradiation was associated with a higher mortality for lesions in the mid third part of the esophagus, 11 of 29 versus four of 19, but again, the difference was not significant. In the irradiated patients, the five year actuarial postoperative survival rate was 9.5 versus 11.5 per cent for the nonirradiated patients. In conclusion, preoperative radiation therapy does not produce a statistically significant short term or long term benefit in the management of squamous cell carcinoma of the esophagus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794167

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  39 in total

Review 1.  Neoadjuvant treatment of esophageal cancer.

Authors:  Nicholas P Campbell; Victoria M Villaflor
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

2.  [Neoadjuvant therapy for squamous cell carcinoma of the esophagus].

Authors:  F Lordick
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

Review 3.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

Review 4.  Perioperative therapy for esophageal cancer.

Authors:  Makoto Yamasaki; Hiroshi Miyata; Yasuhiro Miyazaki; Tsuyoshi Takahashi; Yukinori Kurokawa; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-29

Review 5.  Role of radiotherapy in the pre-operative management of carcinoma of the esophagus.

Authors:  Bryan H Burmeister
Journal:  World J Gastrointest Oncol       Date:  2015-01-15

6.  Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results.

Authors:  Nicolas Plaisant; Pierre Senesse; David Azria; Claire Lemanski; Marc Ychou; Francois Quenet; Bernard Saint-Aubert; Philippe Rouanet
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

7.  The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C.

Authors:  M Gignoux; A Roussel; B Paillot; M Gillet; P Schlag; J P Favre; O Dalesio; M Buyse; N Duez
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

Review 8.  Multimodal treatment for squamous cell esophageal cancer.

Authors:  U Fink; H J Stein; H Wilke; J D Roder; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 9.  Multimodality approach for locally advanced esophageal cancer.

Authors:  Khaldoun Almhanna; Jonathan R Strosberg
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 10.  Advanced esophageal carcinoma.

Authors:  T E Lerut; P de Leyn; W Coosemans; D Van Raemdonck; P Cuypers; B Van Cleynenbreughel
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.